I am a
Home I AM A Search Login

Papers of the Week


Papers: 1 Feb 2025 - 7 Feb 2025


2025 Jan 29


Neuron


39892387

Editor's Pick

Divergent sex-specific pannexin-1 mechanisms in microglia and T cells underlie neuropathic pain.

Authors

Fan CY, McAllister BB, Stokes-Heck S, Harding EK, Pereira de Vasconcelos A, Mah LK, Lima LV, van den Hoogen NJ, Rosen SF, Ham B, Zhang Z, Liu H, Zemp FJ, Burkhard R, Geuking MB, Mahoney DJ, Zamponi GW, Mogil JS, Ousman SS, Trang T

Abstract

Chronic pain is a leading cause of disability, affecting more women than men. Different immune cells contribute to this sexual divergence, but the mechanisms, especially in females, are not well defined. We show that pannexin-1 (Panx1) channels on microglia and T cells differentially cause mechanical allodynia, a debilitating symptom of neuropathic pain. In male rodents, Panx1 drives vascular endothelial growth factor-A (VEGF-A) release from microglia. Cell-specific knockdown of microglial Panx1 or pharmacological blockade of the VEGF receptor attenuated allodynia in nerve-injured males. In females, nerve injury increased spinal CD8 T cells and leptin levels. Leptin release from female-derived CD8 T cells was Panx1 dependent, and intrathecal leptin-neutralizing antibody injection sex-specifically reversed allodynia. Adoptive transfer of female-derived CD8 T cells caused robust allodynia, which was prevented by a leptin-neutralizing antibody or leptin small interfering RNA (siRNA) knockdown. Panx1-targeted approaches may alleviate neuropathic pain in both sexes, while T cell- and leptin-directed treatments could have sex-dependent benefits for women.